Because Ndrg2-deficient mice developed various types of tumors including T cell lymphoma15, we also analyzed the activation status of the NF-κB signaling pathway in Ndrg2-deficient lymphoma cells (Fig. 3b). The gene discussed is NFKB1; the disease is lymphoma.